<TEI xmlns="http://www.tei-c.org/ns/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.tei-c.org/ns/1.0 /home/abel/Downloads/grobid-0.5.6/grobid-home/schemas/xsd/Grobid.xsd" xml:space="preserve">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">LETTERS TO THE EDITOR</title>
			</titleStmt>
			<publicationStmt>
				<publisher />
				<availability status="unknown"><licence /></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<title level="a" type="main">LETTERS TO THE EDITOR</title>
					</analytic>
					<monogr>
						<imprint>
							<date />
						</imprint>
					</monogr>
					<note>Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC Dear Editor, www.elsevierhealth.com/journals/jinf Journal of Infection (2013) 67, 348e358</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>

		<encodingDesc>
			<appInfo>
				<application ident="GROBID" version="0.5.6" when="2020-03-16T22:29+0000">
					<ref target="https://github.com/kermitt2/grobid">GROBID - A machine learning software for extracting information from scholarly documents</ref>
				</application>
			</appInfo>
		</encodingDesc>		<profileDesc>
			<abstract />
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div><p>Most recently, Chan et al. </p><p>To prove this, we first tested the reactivity of a series of SARS-CoV RBD-specific monoclonal antibodies (mAbs) </p><p>We next detected the neutralizing activity of the representative SARS-CoV S-RBD-specific neutralizing mAbs against hCoV-EMC infection in Huh-7 cells that express DPP4 receptor for hCoV-EMC 4 and against SARS-CoV infection in ACE2/293T cells expressing the receptor for SARS-CoV, 7 using our established pseudovirus neutralization assay. As shown in </p><p>To further confirm our conclusion, we performed another experiment to test the neutralizing activity of antibodies in the sera of SARS-CoV S-RBD proteinvaccinated mice. As shown in </p><p>By bioinformatic analysis of S proteins of SARS-CoV and hCoV-EMC, Chan et al. </p></div>
<div><head>Potentials conflicts of interest</head><p>On behalf of the British Infection Society, Heyderman recently published the second edition of guidelines for the management of bacterial meningitis in adults. </p><p>We retrospectively analysed medical records of all patients with confirmed pneumococcal meningitis hospitalized at the ICU of Bichat e Claude Bernard, a 1000 bed university hospital, from January 2000 to February 2011. It is our policy to admit all patients with confirmed pneumococcal meningitis for the first 24 h. Our local ethics committee approved the study and waived individual consent.</p><p>We collected characteristics of each patient at admission in the ICU, at the time of RLP, or at day 3 in case of no RLP. Data were collected from both diagnostic lumbar puncture (DLP) and the first RLP. The reasons to perform RLP were either persistent coma or the inability to evaluate consciousness because of sedation. If a patient had no registered Glasgow Coma Scale (GCS) score at day 3 we used the GCS score at admission, unless it was indicated that the patient was in a coma (registered GCS of 6) or confirmed brain death (registered GCS of 3). Surgical procedures and computer tomography (CT) abnormalities were collected.</p><p>The minimum inhibitory concentrations (MIC) of penicillin, amoxicillin and cefotaxime were recorded. Susceptibility to penicillin was defined as sensitive for MIC &lt;0.06 mg/L, intermediate for MIC between 0.06 and 0.12 mg/L, and resistant for MIC &gt;0.12 mg/L. The first line recommended regimen included third generation cephalosporin with the adjunction of vancomycin in the case of a suspected penicillin resistant strain or a severe case (septic shock or deep coma).</p></div><figDesc>No reported conflicts.</figDesc></body>
		<back>

			<div type="acknowledgement">
<div><head>Acknowledgments</head><p>The authors were partially supported by the grant from the National Institutes of Health (R01AI098775).</p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Cross-reactive antibodies in convalescent SARS patients' sera against the emerging novel human coronavirus EMC (2012) by both immunofluorescent and neutralizing antibody tests</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">H</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Fuk-Woo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Tse</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">C</forename><surname>Choi-Yi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Cai</surname></persName>
		</author>
		<idno type="DOI">10.1016/j.jinf.2013.03.015</idno>
		<ptr target="http://dx.doi.org/10.1016/j.-jinf.2013.03.015" />
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<date type="published" when="2013-04-10" />
		</imprint>
	</monogr>
	<note>Epub ahead of print</note>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus</title>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Vasilieva</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Sui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Berne</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">426</biblScope>
			<biblScope from="450" to="454" unit="page" />
			<date type="published" when="2003" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">193-amino acid fragment of the SARS coronavirus S protein efficiently binds angiotensin-converting enzyme 2</title>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Wong</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Moore</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Farzan</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">279</biblScope>
			<biblScope from="3197" to="201" unit="page" />
			<date type="published" when="2004" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC</title>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">S</forename><surname>Raj</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Mou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Smits</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">H</forename><surname>Dekkers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Muller</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Dijkman</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nature</title>
		<imprint>
			<biblScope unit="volume">495</biblScope>
			<biblScope from="251" to="255" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">A predicted receptor-binding and critical neutralizing domain in S protein of the novel human coronavirus HCoV-EMC</title>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">K</forename><surname>Debnath</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">66</biblScope>
			<biblScope from="464" to="470" unit="page" />
			<date type="published" when="2013" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Receptor-binding domain of severe acute respiratory syndrome coronavirus spike protein contains multiple conformation-dependent epitopes that induce highly potent neutralizing antibodies</title>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Lu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Siddiqui</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">174</biblScope>
			<biblScope from="4908" to="4923" unit="page" />
			<date type="published" when="2005" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">Recombinant receptor-binding domain of SARS-CoV spike protein expressed in mammalian, insect and E. coli cells elicits potent neutralizing antibody and protective immunity</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Zhao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Sun</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Z</forename><surname>Liu</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Virology</title>
		<imprint>
			<biblScope unit="volume">393</biblScope>
			<biblScope from="144" to="50" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The spike protein of SARS-CoV e a target for vaccine and therapeutic development</title>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Zheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Jiang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Rev Microbiol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope from="226" to="262" unit="page" />
			<date type="published" when="2009" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">M</forename><surname>Zaki</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Van</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Bestebroer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Osterhaus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Fouchier</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">N Engl J Med</title>
		<imprint>
			<biblScope unit="volume">367</biblScope>
			<biblScope from="1814" to="1834" unit="page" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">Is the discovery of the novel human betacoronavirus 2c EMC/2012 (HCoV-EMC) the beginning of another SARS-like pandemic</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Chan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">S</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">K</forename><surname>To</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><forename type="middle">C</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Chen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">Y</forename><surname>Yuen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Infect</title>
		<imprint>
			<biblScope unit="volume">65</biblScope>
			<biblScope from="477" to="89" unit="page" />
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">Identification and characterization of novel neutralizing epitopes in the receptorbinding domain of SARS-CoV spike protein: revealing the critical antigenic determinants in inactivated SARS-CoV vaccine</title>
		<author>
			<persName><forename type="first">Y</forename><surname>He</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Du</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Yan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Hu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Zhou</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Vaccine</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope from="5498" to="508" unit="page" />
			<date type="published" when="2006" />
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">Human monoclonal antibodies against highly conserved HR1 and HR2 domains of the SARS-CoV spike protein are more broadly neutralizing</title>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">A</forename><surname>Elshabrawy</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">M</forename><surname>Coughlin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Baker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">S</forename><surname>Prabhakar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">50366</biblScope>
			<date type="published" when="2012" />
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>